About this reference
GLP1Meds.org is a medication reference. The job of a monograph is to say what a U.S. label says a drug is for, how the labeled dose moves, and which trial reported which average. It is not a buying guide and not a list of preferred telehealth brands.
Scope
We cover semaglutide, tirzepatide, and liraglutide products with public labels, plus the distinction between those products and compounded or unapproved versions. We do not describe pipeline drugs as if they were approved. If a federal page lists a product we have not read a label for, we say that we have not read the label.
The site sits in an educational network that also publishes consumer and coverage pages and that has a relationship with SurpassMD. Monographs do not link to that practice as a default. Cost questions are sent to coverage pages and manufacturer price pages. Read the editorial method.